• Home
  • About us
  • Our products
  • Your health
  • Responsibility
  • In the community
  • Research & development
  • Investors
  • Media centre
  • Careers
GlaxoSmithKline logo

Non-routine waste

Non-routine waste is primarily building materials from site demolition and construction activities and from small remediation projects. In 2005, we disposed (via landfill or incineration) of 37 million kg of non-routine waste, and recycled 40 million kg.

Performance

Non-routine waste

Note to non-routine waste charts
Although the external definition of what constitutes waste varies, for GSK reporting purposes a material is considered a waste if it is no longer fit for its originally intended purpose.

Non-routine waste disposal includes disposal to landfill and incineration either on or off GSK property. Incineration with energy recovery includes processes that result in beneficial energy or resource recovery. We also recycle non-routine waste whenever that is feasible.

The amount of waste fluctuates each year depending on plant upgrades and site closures. In 2005 new building at one of our vaccine plants accounted for nearly half of the non-routine waste

Rather than sending this waste to landfill, the plant was able to provide excavated soil from the building expansion to another company to be used as clean fill.


* Back to top


This section contains information in several formats:

To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.

For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.